Peptide inhibitors of ABL kinases

Details for Australian Patent Application No. 2006320699 (hide)

Owner New York Blood Center, Inc.

Inventors Kotula, Leszek; Xiong, Xiaoling

Agent Davies Collison Cave

Pub. Number AU-A-2006320699

PCT Pub. Number WO2007/064647

Priority 60/741,208 01.12.05 US

Filing date 29 November 2006

Wipo publication date 7 June 2007

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/064647 Priority application(s): WO2007/064647

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006320711-Conveyor plate with integrated roller

2006320693-Social and interactive applications for mass media